Geneos Wealth Management’s Core Alternative Capital CCOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-397
Closed -$10.9K 2140
2023
Q4
$10.9K Hold
397
﹤0.01% 1526
2023
Q3
$10.9K Sell
397
-67
-14% -$1.87K ﹤0.01% 1542
2023
Q2
$13K Buy
464
+1
+0.2% +$29 ﹤0.01% 1501
2023
Q1
$13.8K Buy
463
+70
+18% +$2.13K ﹤0.01% 1458
2022
Q4
$12.4K Buy
+393
New +$12.4K ﹤0.01% 1472

Other funds holding CCOR

Geneos Wealth Management's CCOR Position: Q1 2024 in Review

Geneos Wealth Management sold out of Core Alternative Capital (CCOR) in Q1 2024, closing a stake of 397 shares — an estimated $10.9K sold.

Geneos Wealth Management first reported a position in CCOR in Q4 2022 and held it in 5 quarters. The position peaked at $13.8K in Q1 2023. 40 funds tracked by Wall St. Rank hold CCOR as of Q1 2024.

  • Geneos Wealth Management reported no remaining Core Alternative Capital position as of Q1 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 397 Core Alternative Capital shares in Q1 2024, an estimated $10.9K.
  • Geneos Wealth Management first reported a position in Core Alternative Capital in Q4 2022 and held it in 5 quarters.
  • Geneos Wealth Management's Core Alternative Capital position peaked at $13.8K in Q1 2023.
  • 40 funds tracked by Wall St. Rank held Core Alternative Capital as of Q1 2024.

Based on Geneos Wealth Management's 13F filing for Q1 2024, filed 3 May 2024.